
Results 1 - 20 of 82 in Actos, Pioglitazone (generic)
Evidence for the Importance of Adiponectin in the Cardioprotective...
From the Department of Cardiology, Graduate School of Medicine , Department of Medical Technology, School of Health Science , and Department of Cardiovascular Research Medicine, School of Medicine , Nagoya University, Nagoya, Japan; Molecular Cardiology , Boston University School of Medicine, Boston, Mass. Comment?
Diabetes drugs double women's fracture risk
Long-term use of GlaxoSmithKline's Avandia and Takeda's Actos doubles the risk of bone fractures in women with type 2 diabetes, according to a study released on Wednesday. Comment?
Study links diabetes drug to heart failure
A diabetes drug used by tens of thousands of Canadians increases the risk of heart attack, heart failure and death in older patients, concludes a vast new Ontario study that suggests Avandia's dangers may often outweigh its benefits. Comment?
The Truth About Afresa Inhalable Insulin: A Chat with Al Mann
w/Photo
"What a wonderful book! Diabetes can feel confusing and overwhelming, but it doesn't have to be a ' especially thanks to books like this." a ' Dr. Comment?
Diagnosis: type 2 diabetes - now what?
w/Photo
This month is American Diabetes Month . There are many souces that cover the likely causes of type 2 diabetes and the symptoms. Comment?
Thiazolidinediones Reduce Pathological Neovascularization in Ischemic ...
From the Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass ; and the Department of Cardiology, Nagoya University Graduate School of Medicine, Japan . Comment?
Diabetes drug could lead to heart failure: Study
New research involving nearly 40,000 Ontario patients is questioning the use of a widely prescribed diabetes drug that an expert in drug safety says should be removed from the market Photograph by: Bill Keay, Vancouver Sun New research involving nearly 40,000 Ontario patients is questioning the use of a widely prescribed diabetes drug that an ... Comment?
The World Diabetes Market, 2007-2025: By 2025 It Is Expected That...
w/Photo
The World Diabetes Market, 2007-2025: An analysis of Diabetes Drug and Insulin Market gives a detailed analysis on the global diabetes market. Comment?
Marshfield Clinic seeks volunteers for diabetes study
Marshfield Clinic researchers are seeking volunteers with Type 2 diabetes for a research study that will look at the effectiveness and safety of an investigational diabetes medication combination. Comment?
Takeda Agrees to Pay Amylin as Much as $1 Billion to Develop Obesity Drugs
w/Photo
Takeda Pharmaceutical Co. , maker of the worlda s best-selling diabetes drug, agreed to pay as much as $1 billion to Amylin Pharmaceuticals Inc. Comment?
Takeda Agrees to Pay Amylin as Much as $1 Billion to Develop Obesity Drugs
Takeda Pharmaceutical Co. , maker of the worlda s best-selling diabetes drug, agreed to pay as much as $1 billion to Amylin Pharmaceuticals Inc. Comment?
In a randomized, double-blind, placebo-controlled trial of 247 patients who had NASH but not diabetes, pioglitazone improved key histological features and liver enzymes; however, vitamin E was more successful for the treatment of NASH in these patients. Comment?
Early diabetes treatment key for long term health: study
People with diabetes given intensive drug treatment soon after diagnosis are healthier when they grow older, even if they become less rigorous about controlling their blood sugar later on, British researchers said on Wednesday. Comment?
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary...
Main Category: Diabetes Also Included In: Clinical Trials / Drug Trials Article Date: 29 Oct 2009 - 10:00 PDT Ipsen , an innovation-driven global specialty pharmaceutical group, announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 ... Comment?
Healthy Habits Can Delay Diabetes 10 Years
Healthy habits and weight loss can delay diabetes for 10 years in high-risk people, a new study has found. Comment?
Roche, Ipsen Diabetes Drug Meets Late-Stage Target
Regulatory News: Ipsen , an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 analogue originating from Ipsen's Research. Comment?
Prescription drugs stolen from car
Your account has been frozen . For your available options click the below button. Comment?
Glaxo diabetes drug should stay on market: U.S. panel
GlaxoSmithKline Plc's diabetes pill Avandia should stay on the market even though data suggest it may raise the risk of a heart attack for some patients, U.S. advisers said on Monday. Comment?
Advances in the Treatment of Type 2 Diabetes Mellitus.
The associated complications of diabetes, such as cardiovascular disease, peripheral vascular disease, stroke, diabetic neuropathy, amputations, renal failure, and blindness result in increasing disability, reduced life expectancy, and enormous health costs. Comment?
New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions
A study, published online in the journal Current Medical Research and Opinion , showed that a greater percentage of patients with type 2 diabetes treated with the fixed-dose combination ACTOplus met as initial therapy reached the study goal of hemoglobin A1c of a3 percent included: headache at 5.5 percent, pharyngitis and nasopharyngitis each at 4 ... Comment?